Benchmark Reiterates Buy on NOV, Maintains $28 Price Target
Portfolio Pulse from richadhand@benzinga.com
Benchmark analyst Kurt Hallead has reiterated a 'Buy' rating on NOV (NYSE:NOV) and maintained a price target of $28.
July 31, 2023 | 12:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Benchmark analyst Kurt Hallead has reiterated a 'Buy' rating on NOV and maintained a price target of $28.
The reiteration of a 'Buy' rating by a Benchmark analyst and the maintenance of a $28 price target could potentially boost investor confidence in NOV, leading to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100